These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1547455)

  • 1. The potential of ytterbium 169 in brachytherapy: a brief physical and radiobiological assessment.
    Loft SM; Coles IP; Dale RG
    Br J Radiol; 1992 Mar; 65(771):252-7. PubMed ID: 1547455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumour shrinkage on the biological effectiveness of permanent brachytherapy implants.
    Dale RG; Jones B; Coles IP
    Br J Radiol; 1994 Jul; 67(799):639-45. PubMed ID: 8061998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactivity measurements of ytterbium-169 brachytherapy sources.
    MacPherson MS; Battista JJ
    Australas Phys Eng Sci Med; 1998 Mar; 21(1):18-23. PubMed ID: 9633149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy.
    Mason DL; Battista JJ; Barnett RB; Porter AT
    Med Phys; 1992; 19(3):695-703. PubMed ID: 1508110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.
    Dale RG
    Br J Radiol; 1989 Mar; 62(735):241-4. PubMed ID: 2702381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
    Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
    Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants.
    Lazarescu GR; Battista JJ
    Phys Med Biol; 1997 Sep; 42(9):1727-36. PubMed ID: 9308079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation guidelines for 169 Yb seed interstitial treatments.
    Piermattei A; Azario L; Montemaggi P
    Phys Med Biol; 1995 Aug; 40(8):1331-8. PubMed ID: 7480116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interstitial radiotherapy].
    Hammer J
    Wien Med Wochenschr; 1983 Jun; 133(12):307-9. PubMed ID: 6684364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
    Viola A; Major T; Julow J
    Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel ytterbium-169 brachytherapy source and delivery system for use in conjunction with minimally invasive wedge resection of early-stage lung cancer.
    Leonard KL; DiPetrillo TA; Munro JJ; Wazer DE
    Brachytherapy; 2011; 10(2):163-9. PubMed ID: 20705525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rigid phantom dosimetry of brachytherapy sources, with special reference to 125-I].
    Arcovito G; Piermattei A; Bacci C; Pittella G; Castagnola M
    Radiol Med; 1985 Jun; 71(6):426-32. PubMed ID: 4070702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model.
    Ling CC
    Int J Radiat Oncol Biol Phys; 1992; 23(1):81-7. PubMed ID: 1572833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient
    Flynn RT; Adams QE; Hopfensperger KM; Wu X; Xu W; Kim Y
    Med Phys; 2019 Jul; 46(7):2935-2943. PubMed ID: 31054163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-153 as a brachytherapy isotope.
    Enger SA; Fisher DR; Flynn RT
    Phys Med Biol; 2013 Feb; 58(4):957-64. PubMed ID: 23339848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdosimetric single event spectra of Ytterbium-169 compared with commonly used brachytherapy sources and teletherapy beams.
    Zellmer DL; Gillin MT; Wilson JF
    Int J Radiat Oncol Biol Phys; 1992; 23(3):627-32. PubMed ID: 1612963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS; Chen J
    Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rat solid tumor model for continuous low-dose-rate irradiation studies using 125I and 103Pd sources.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Brachytherapy; 2004; 3(3):159-72. PubMed ID: 15533809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate brachytherapy: comparison of dose distribution with different 125I source designs.
    Beyer DC; Puente F; Rogers KL; Gurgoze EM
    Radiology; 2001 Dec; 221(3):623-7. PubMed ID: 11719655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.